Direct requirement for Xmus101 in ATR-mediated phosphorylation of Claspin bound Chk1 during checkpoint signaling by Yan, Shan et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
JCB: REPORT
© The Rockefeller University Press    $8.00
The Journal of Cell Biology, Vol. 173, No. 2, April 24, 2006 181–186
http://www.jcb.org/cgi/doi/10.1083/jcb.200601076
JCB 181
Introduction
Replication checkpoint signaling initiates when the DNA struc-
tures that form at stalled replication forks activate the ataxia-
  telangiectasia and Rad-3–related (ATR) protein kinase (for review 
see Sancar et al., 2004). ATR then phosphorylates and activates 
the Chk1 kinase. The pathway leading from activated ATR to 
Chk1 is complex and involves numerous intermediaries. In fi  s-
sion yeast, activation of Chk1 by the ATR homologue Rad3 re-
quires, amongst other factors, Rad9, Crb2, and Cut5. Cut5 plays 
a central role in transducing the checkpoint signal from acti-
vated Rad3 to Chk1, as it forms complexes with both Crb2 and 
Rad9 (for review see Garcia et al., 2005). In metazoans, Chk1 
activation also requires ATR, Rad9, and the Cut5 homologue 
TopBP1/Mus101. Despite this conservation, there is an impor-
tant difference between the fi  ssion yeast and metazoan Chk1 
  activation pathways. In metazoans, the Claspin protein plays an 
essential role in Chk1 activation (Kumagai and Dunphy, 2000), 
whereas in fi  ssion yeast the Claspin homologue Mrc1 is not 
  involved (Tanaka and Russell, 2001). Likewise, in fi  ssion yeast, 
Crb2 is essential for Chk1 activation (Saka et al., 1997), whereas 
in metazoans the Crb2 homologue 53BP1 is not known to be in-
volved. Because Crb2/53BP1 is not required for Chk1 activation 
in metazoans, it is unclear what role, if any, TopBP1/Mus101 
plays in promoting activation of Chk1 by ATR.
Cut5/TopBP1 is unique amongst Chk1 activators in that 
it is also essential for DNA replication (Garcia et al., 2005). 
This is an important feature of Cut5/TopBP1, as replication is 
required to generate the DNA structures that activate ATR and 
initiate the checkpoint response (Michael et al., 2000). In fi  s-
sion yeast, temperature-sensitive alleles of Cut5 have allowed 
a  separation of the replication and checkpoint functions of 
the protein (Garcia et al., 2005); however, it is not yet known 
if the replication function can be uncoupled from checkpoint 
function for TopBP1. One recent study of the Xenopus laevis 
TopBP1 homologue Xmus101 (also known as Xcut5) showed 
that Xmus101 is required to recruit both ATR and DNA poly-
merase α (pol α) to chromatin during a checkpoint response 
(Parrilla-Castellar and Karnitz, 2003). Pol α is required to gen-
erate the DNA structures that activate ATR (Michael et al., 
2000), and it is therefore possible that the role of Xmus101 in 
Chk1 activation is limited to this early phase of the process. 
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opBP1-like proteins, which include Xenopus laevis 
Xmus101, are required for DNA replication and 
have been linked to replication checkpoint control. 
A direct role for TopBP1/Mus101 in checkpoint control 
has been difﬁ   cult to prove, however, because of the 
  requirement for replication in generating the DNA struc-
tures that activate the checkpoint. Checkpoint activation 
occurs in X. laevis egg extracts upon addition of an oligo-
nucleotide duplex (AT70). We show that AT70 bypasses 
the requirement for replication in checkpoint activation. 
We take advantage of this replication-independent check-
point system to determine the role of Xmus101 in the 
checkpoint. We ﬁ  nd that Xmus101 is essential for AT70-
mediated checkpoint signaling and that it functions to 
  promote phosphorylation of Claspin bound Chk1 by the 
ataxia-  telangiectasia and Rad-3–related (ATR) protein 
  kinase. We also identify a separation-of-function mutant 
of Xmus101. In extracts expressing this mutant, replica-
tion of sperm chromatin occurs normally; however, the 
checkpoint response to stalled replication forks fails. These 
data demonstrate that Xmus101 functions directly during 
signal relay from ATR to Chk1.
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  Alternatively, Xmus101 could also have a later function, during 
relay of the checkpoint signal from activated ATR to Chk1. The 
differences in the mechanism of this signal relay between fi  s-
sion yeast and metazoans preclude clear predictions about what 
role, if any, Xmus101 might play in promoting phosphorylation 
of Chk1 by ATR. To address this important issue, we have used 
conditions in X. laevis egg extracts that bypass the requirement 
for pol α and for generating DNA structures in activating Chk1. 
We report on the role that Xmus101 plays in Chk1 activation 
under these bypass conditions. Our results demonstrate that 
Xmus101 has a late checkpoint function, to promote phosphor-
ylation of Chk1 by activated ATR.
Results and discussion
AT70-mediated Chk1 activation
To study Chk1 activation, we used the AT70 system in X. laevis 
egg extracts (Kumagai and Dunphy, 2000). In this system, two 
short oligonucleotides, A70 and T70, are annealed to one 
  another and then added to extracts. Addition of the duplex, but 
not either single oligonucleotide alone, triggers robust Chk1 
phosphorylation. Chk1 activation in this system is dependent 
on ATR, Claspin, and other checkpoint proteins (Kumagai and 
Dunphy, 2000, 2003; Jeong et al., 2003). To monitor checkpoint 
activation, we used a previously established assay based on a 
fragment of the X. laevis Chk1 protein, Chk1∆KD, that is phos-
phorylated in an ATR- and Claspin-dependent manner in egg 
extracts (Michael et al., 2000; Jeong et al., 2003). Phosphoryla-
tion of Chk1∆KD results in an easily detectable mobility shift 
on SDS-PAGE gels. An example of the AT70 checkpoint system 
is shown in Fig. 1 A. Egg extracts were supplemented with 
Chk1∆KD and either the single A70 oligonucleotide, the AT70 
duplex, or no DNA at all. After a 100-min incubation, samples 
were taken and probed by immunoblotting for Chk1∆KD. 
A Chk1∆KD mobility shift was observed in the samples con-
taining AT70 (Fig. 1 A, lane 3) but not in the sample containing 
A70 (lane 2) or no DNA (lane 1). This demonstrates that 
AT70   specifi   cally triggers Chk1∆KD phosphorylation. 
 Control   experiments, detailed in the supplemental text (available 
at http://www.jcb.org/cgi/content/full/jcb.200601076/DC1), 
showed conclusively that Chk1∆KD is a reliable surrogate for 
the endogenous Chk1 in these assays (Fig. S1).
Xmus101, but not minichromosome 
maintenance (MCM) complex or pol 𝗂, 
is required for Chk1 activation 
in the AT70 system
Previous work has shown that when sperm chromatin and the 
DNA replication inhibitor aphidicolin are used to activate the 
checkpoint in egg extracts, both the MCM complex and pol α 
are required for Chk1 activation (Michael et al., 2000). Both of 
these proteins promote replication (for review see Bell and 
Dutta, 2002). The MCM complex is a hexameric assembly that 
unwinds DNA during replication, whereas pol α synthesizes the 
primers that initiate replication. To determine whether these 
proteins are required for Chk1 activation in the AT70 system, 
we removed MCM and pol α by immunodepletion. Fig. 1 B 
shows that all detectable MCM5 protein was removed from the 
extract, and Fig. 1 C shows that same was true of the p70 sub-
unit of pol α. Despite the loss of MCM and pol α in these ex-
tracts, addition of AT70 still activated Chk1, as shown by 
Chk1∆KD mobility shift (Fig. 1 D). MCM and pol α are thus 
dispensable for Chk1 activation in the AT70 system. We con-
clude that the AT70 system bypasses the requirement for repli-
cation proteins in Chk1 activation.
If the role of Xmus101 in Chk1 activation was restricted 
to generating the checkpoint-activating DNA structure, then it, 
like MCM and pol α, should be dispensable for Chk1 activation 
in the AT70 system. To address this, Xmus101 was removed 
from extract by immunodepletion (Fig. 1 E) and the samples 
Figure 1.  Xmus101 is required, but replication proteins are not, for Chk1 
activation in the AT70 system. (A) Recombinant Chk1∆KD was added to 
extract, along with no DNA (lane 1), the A70 oligonucleotide (lane 2), or 
the preannealed AT70 oligonucleotide (lane 3). After a 100-min incuba-
tion, samples were taken and the phosphorylation status of Chk1∆KD was 
assessed by SDS-PAGE and immunoblotting with the T7 monoclonal anti-
body (Novagen), which recognizes the T7 epitope tag present on recombi-
nant Chk1∆KD. The retarded mobility of Chk1∆KD in lane 3 is due to 
phosphorylation (Michael et al., 2000). (B) MCM5 was immunodepleted 
from egg extract. The depleted extract was probed for MCM5 by immuno-
blotting and compared with a mock-depleted extract. (C) Same as B except 
that the p70 subunit of pol α was immunodepleted. (D) Mock-depleted and 
depleted extracts were supplemented with recombinant Chk1∆KD and 
AT70. After a 100-min incubation, samples were taken and processed as 
in A. The lanes labeled “no DNA” refer to extracts incubated without AT70 
but with recombinant Chk1∆KD. (E) Xmus101 was immunodepleted from 
egg extracts. The depleted extracts were probed for Xmus101 by immuno-
blotting and compared with a mock-depleted extract. Add-back refers 
  to Xmus101-depleted extracts supplemented with recombinant Xmus101. 
(F) The extracts depicted in E were assayed for Chk1∆KD phosphorylation 
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were assayed for Chk1 activation after addition of AT70. As 
shown in Fig. 1 F, and in contrast to MCM and pol α, removal 
of Xmus101 prevented Chk1∆KD phosphorylation. Impor-
tantly, Chk1 activation was restored in Xmus101-depleted ex-
tract after supplementation of the extract with recombinant 
Xmus101 that had been produced in rabbit reticulocyte lysates 
(Fig. 1 F). Supplementation of Xmus101-depleted extract with 
unprogrammed reticulocyte lysates did not rescue Chk1∆KD 
phosphorylation (unpublished data). We conclude that Xmus101 
is essential for Chk1 activation in the AT70 system. This result 
thus distinguishes Xmus101 from the replication fork com-
ponents MCM and pol α and demonstrates that the role of 
Xmus101 in Chk1 activation extends beyond generating the 
checkpoint-activating DNA structure.
A neutralizing antibody and a dominant-
negative fragment inhibit Xmus101 
function during Chk1 activation
We considered the possibility that our anti-Xmus101 antibody, 
HU142, might inhibit Xmus101 function when added to extract. 
To test this, we added purifi  ed HU142 antibody directly to ex-
tract along with AT70. Addition of HU142 prevented AT70-
  induced phosphorylation of Chk1∆KD, whereas nonspecifi  c IgG 
did not (Fig. 2 B). This result demonstrates that HU142, which 
recognizes the COOH-terminal 333 amino acids of Xmus101 
(Fig. 2 A), blocks AT70-mediated checkpoint signaling. One 
explanation for this is that binding of HU142 to the COOH-
  terminal 333 amino acids of Xmus101 prevents an interaction 
between this region and a factor that is required for checkpoint 
signaling. If so, then we might expect overexpression of the 
  isolated 333 amino acid domain to also inhibit Chk1 activation 
through sequestration of this presumptive factor away from the 
full-length endogenous Xmus101. To test this, we titrated a re-
combinant protein consisting of GST fused to the 333 COOH-
terminal amino acids of Xmus101 (GST-CT333; Fig. 2 A) into 
extracts and then added AT70 to activate Chk1. As shown in 
Fig. 2 C, addition of GST-CT333, but not GST alone, inhibited 
Chk1∆KD phosphorylation in a dose-dependent manner. We 
conclude that when the function of the extreme COOH terminus 
of endogenous Xmus101 is antagonized, through either binding 
of HU142 or overexpression of the isolated domain, then Chk1 
activation is blocked.
Identiﬁ  cation of the Xmus101-dependent 
step in Chk1 activation
The results in Figs. 1 and 2 show that loss of Xmus101 blocks 
AT70-mediated Chk1 activation and that two independent in-
hibitors of Xmus101, a neutralizing antibody and a dominant-
negative fragment, do the same. We next used these inhibitors 
to defi   ne the Xmus101-dependent step in Chk1 activation. 
In X. laevis, Chk1 activation is (minimally) a three-step process 
(Fig. 3 A). Upon ATR activation, the fi  rst identifi  able step is 
phosphorylation of the Claspin Chk1 binding domain (CKBD; 
Kumagai and Dunphy, 2003). This phosphorylation is ATR de-
pendent and thus also serves as an indicator of ATR activation. 
After Claspin CKBD phosphorylation, the next step (step 2) is 
assembly of a Claspin–Chk1 complex. Claspin–Chk1 complex 
assembly is dependent on step 1 and is required for step 3 in the 
Figure 2.  Two inhibitors of the Xmus101 Chk1 activation function. 
(A) A cartoon of Xmus101 showing the region of the protein that was used 
as antigen to produce the HU142 antibody as well as recombinant   proteins 
used in this study. The numbered boxes refer to BRCT domains (Garcia 
et al., 2005). (B) Extracts were supplemented with either nonspeciﬁ  c IgG 
(lane 1) or HU142 (lane 2; ﬁ  nal concentration: 50 ng/μl). Both samples 
were then further supplemented with recombinant Chk1∆KD and AT70. 
  After a 100-min incubation, samples were taken and probed for Chk1∆KD 
as in Fig. 1 A. (C) Either GST (15 μM; lane 1) or GST-CT333 (806 nM, 
lane 2; 322 nM, lane 3; 161 nM, lane 4) was added to egg extract along 
with AT70 and Chk1∆KD. After a 100-min incubation, samples were taken 
and probed for Chk1∆KD as in Fig. 1 A.
Figure 3.  Xmus101 functions after assembly of the Claspin–Chk1 complex 
during AT70-mediated Chk1 activation. (A) A depiction of the Chk1 activa-
tion pathway. (B) Extracts were supplemented with recombinant GST-
Claspin CKBD and the following additional components: buffer (lane 1), 
the A70 oligonucleotide (lane 2), preannealed AT70 oligonucleotides (lane 3), 
or preannealed AT70 oligonucleotides plus HU142 (ﬁ  nal concentration: 
50 ng/μl; lane 4). GST-Claspin CKBD phosphorylation was assessed after 
a 100-min incubation, according to published procedures (Kumagai and 
Dunphy, 2003). (C) GST-Claspin CKBD shift assay in extracts containing 
AT70 and buffer (lane 1), GST (15 μM; lane 2), or GST-CT333 (806 nM; 
lane 3). (D) Extracts were supplemented with bead bound recombinant 
Xchk1-GH (Kumagai and Dunphy, 2000) and the following additional com-
ponents: buffer (lane 1), the A70 oligonucleotide (lane 2), preannealed 
AT70 oligonucleotides (lane 3), or preannealed AT70 oligonucleotides plus 
HU142 (ﬁ  nal concentration: 50 ng/μl; lane 4). After a 100-min incuba-
tion, the beads were isolated and washed, and bound proteins were eluted 
with 2× SDS-PAGE sample buffer. The presence of Claspin and Xchk1-GH 
in the eluate was then determined by immunoblotting with antibodies 
against Claspin and GST, respectively (Jeong et al., 2003). (E) Claspin-
Chk1 binding assay in extracts containing AT70 and buffer (lane 1), GST 
(15 μM; lane 2), or GST-CT333 (806 nM; lane 3).JCB • VOLUME 173 • NUMBER 2 • 2006  184
process, direct phosphorylation of Chk1 by ATR (Kumagai and 
Dunphy, 2003). To assay for completion of step 1, CKBD phos-
phorylation, we used a fragment of Claspin corresponding to 
the CKBD and assessed its phosphorylation by mobility shift on 
SDS-PAGE according to published procedures (Kumagai and 
Dunphy, 2003). The GST-Claspin CKBD did not undergo a 
  mobility shift in extracts that lacked DNA, nor did it shift in   ex-
tracts containing just the A70 oligonucleotide; however, we did 
detect a shift in extracts containing AT70 (Fig. 3 B, lanes 1–3). 
Interestingly, the GST-Claspin CKBD mobility shift occurred 
  normally in extracts containing both AT70 and HU142 (Fig. 
3 B, lane 4). This result shows that although HU142 prevents 
AT70-mediated Chk1∆KD phosphorylation, it has no effect on 
CKBD phosphorylation.
We next determined whether step 2, assembly of a Claspin–
Chk1 complex, occurs in extracts containing Xmus101 inhibi-
tors. For this, we used a previously published Claspin Chk1 
binding assay (Jeong et al., 2003; Kumagai and Dunphy, 2003). 
A full-length GST- and His-tagged Chk1 protein (Xchk1-GH) 
was coupled to Ni–nitrilotriacetic acid (NTA) agarose beads, 
and the beads were then added to extracts. After a 100-min in-
cubation, the beads were recovered, washed, and probed for the 
presence of Claspin by immunoblotting. A Claspin–Chk1 com-
plex could be detected specifi  cally in extracts that had activated 
the checkpoint through addition of AT70 (Fig. 3 D, lane 3) and 
was not detected in extracts lacking DNA or containing A70 
(Fig. 3 D, lanes 1 and 2). Importantly, the Claspin–Chk1 com-
plex readily formed in extracts containing both AT70 and 
HU142 (Fig. 3 D, lane 4). These data demonstrate that HU142 
inhibits the ATR-dependent phosphorylation of Chk1 but not 
assembly of a Claspin–Chk1 complex.
To confi  rm the results obtained with HU142, we repeated 
the experiments with an independent inhibitor of Xmus101 
function, the recombinant GST-CT333 protein. Despite the 
ability of GST-CT333 to prevent phosphorylation of Chk1 (Fig. 
2 C), it had no effect on either mobility shift of GST-Claspin 
CKBD or formation of a Claspin–Chk1 complex (Fig. 3, C 
and E). These results are fully consistent with those obtained with 
HU142 and demonstrate that although the COOH terminus of 
Xmus101 is required for Chk1 phosphorylation, it is not  required 
for the ATR-dependent assembly of a Claspin–Chk1 complex. 
We conclude that one position of Xmus101 in the checkpoint 
activation pathway is after assembly of the Claspin–Chk1 
  complex and before phosphorylation of Chk1 by ATR.
A separation-of-function mutant 
of Xmus101
The results presented thus far show that Xmus101 plays a direct 
role in AT70-mediated Chk1 activation. To see if this is also true 
when checkpoint activation occurs under more physiological 
conditions, we examined the role of Xmus101 in Chk1 activation 
by replication-blocked sperm chromatin templates. Under these 
conditions, Xmus101 is required for replication fork assembly; 
thus, depletion of Xmus101 would indirectly affect Chk1 activa-
tion by virtue of a failure to generate DNA structures. To get 
around this, we asked if we could separate the replication and 
checkpoint functions of Xmus101 mutationally. We constructed 
a deletion mutant of Xmus101 named Mini Xmus101 or Mini 
(Fig. 4 A). Mini corresponds to the fi  rst 759 amino acids of the 
protein and thus lacks the COOH-terminal 333 amino acids that 
have been implicated in Chk1 activation. Endogenous Xmus101 
was immunodepleted, and the depleted extracts were supple-
mented with rabbit reticulocyte lysates that had been programmed 
for in vitro transcription/translation reactions using constructs 
encoding either full-length Xmus101 or Mini. Fig. 4 B shows 
that the full-length Xmus101 and Mini were produced to an 
equivalent extent in the rabbit reticulocyte lysates. The reconsti-
tuted extracts were supplemented with sperm chromatin and 
α-[
32P]dATP, and replication of the sperm chromatin was 
 assessed.  Supplementation of depleted extract with either full-
length Xmus101 or Mini rescued the replication defect com-
pletely, whereas add-back of unprogrammed reticulocyte lysates 
did not promote replication (Fig. 4 C). We conclude that all of the 
replication functions of Xmus101 are contained within Mini.
Because Mini was competent for DNA replication, 
we asked whether it was also suffi  cient for Chk1 activation. 
Figure 4.  A separation-of-function mutant of Xmus101. (A) Schematic 
representations of full-length Xmus101 and Mini. (B) Constructs encoding 
either full-length Xmus101 (FL) or Mini were transcribed and translated in 
vitro in rabbit reticulocyte lysates in the presence of [
35S]methionine. The 
radio-labeled proteins were then run out on SDS-PAGE and visualized after 
autoradiography. (C) Xmus101 was depleted from egg extract. Depleted 
extract was then supplemented (0.1 vol) with either unprogrammed reticu-
locyte lysates (Xmus101
−) or lysates expressing either FL or Mini Xmus101. 
A mock-depleted sample was also prepared. The reconstituted extracts 
were then combined with sperm chromatin and α-[
32P]dATP, and DNA rep-
lication was measured according to standard procedures (Walter and 
Newport, 1999). Samples were taken at 30, 60, and 90 min for analysis. 
(D) The reconstituted extracts described in C were supplemented with 
sperm chromatin and the DNA replication inhibitor aphidicolin (100 μg/ml). 
After a 60-min incubation, the samples were probed by immunoblotting for 
both activated and total Chk1.XMUS101 IN CHECKPOINT CONTROL • YAN ET AL. 185
To examine this, we added sperm chromatin and the DNA poly-
merase inhibitor aphidicolin to extracts that had been immuno-
depleted of Xmus101 and supplemented with either full-length 
Xmus101 or Mini. Chk1 activation was then monitored by im-
munoblotting of the extracts with antibodies specifi  cally recog-
nizing Chk1 that had been phosphorylated on serine 344. Serine 
344–phosphorylated Chk1 represents the activated form (Guo 
et al., 2000). As shown in Fig. 4 D, depletion of Xmus101 pre-
vented Chk1 activation, and this was restored by add-back of 
full-length Xmus101. Importantly, add-back of Mini did not res-
cue Chk1 activation (Fig. 4 D). These data show that Mini is rep-
lication competent and Chk1 activation defi  cient. Based on the 
ability of Mini to separate the replication and Chk1 functions of 
Xmus101, we conclude that Xmus101 functions directly in Chk1 
activation, independent of its role in replication fork assembly.
In a fi  nal experiment, we sought to connect the function 
of Xmus101 in Chk1 activation to the checkpoint response that 
prevents mitosis when replication is blocked. For this, we used 
cycling egg extracts, which when treated with aphidicolin are 
prevented from entering mitosis in a checkpoint-dependent 
manner (Dasso and Newport, 1990). Mitosis was assessed by 
examining sperm nuclei for nuclear envelope breakdown, as 
  described previously (Murray, 1991). Addition of aphidicolin 
delayed mitosis, as expected (Fig. 5 A). Importantly, this delay 
was reversed by addition of the Xmus101 inhibitor HU142 (Fig. 
5 A). HU142 was as effective as the known checkpoint inhibitor 
caffeine in releasing the checkpoint-mediated arrest. Addition of 
HU142 to interphase extracts had no adverse effect on DNA 
replication (Fig. 5 B). We conclude that Xmus101 is required for 
both Chk1 activation and for the checkpoint-mediated delay in 
entrance into mitosis when replication is blocked. Together with 
previous work (Parrilla- Castellar and Karnitz, 2003), the results 
presented here demonstrate that Xmus101 has at least two func-
tions during a checkpoint response: it acts early to recruit ATR 
and pol α to damaged DNA and it functions later to promote 
phosphorylation of Claspin bound Chk1 by activated ATR. The 
challenge for future studies will be to determine the exact mech-
anism whereby Xmus101 performs this late function.
Materials and methods
Extracts and extract procedures
X. laevis egg extract preparation and DNA replication analysis were 
  performed as described previously (Walter and Newport, 1999). For the 
experiment shown in Fig. 5 A, cycling extracts were used, and they were 
prepared as described previously (Murray, 1991). For immunodepletion of 
Xmus101, afﬁ  nity-puriﬁ  ed HU142 antibody was cross-linked to protein A–
Sepharose beads (GE Healthcare) using the dimethylpimelimidate direct-
coupling method, as described previously (Harlow and Lane, 1988). 
Immunodepletion was then performed as described previously (Van Hatten 
et al., 2002). Immunodepletion of pol α has been described (Stokes and 
Michael, 2003), and immunodepletion of MCM5 was performed in an 
analogous manner. A70 and AT70 oligonucleotides were added to 50 
ng/μl of extract, and the phosphatase inhibitor tautomycin was included, 
at 3 μM, as previously described (Kumagai and Dunphy, 2000). For 
Chk1∆KD shift assays, a bacterially expressed recombinant Chk1∆KD 
was added, to 400 nM, to extracts and then visualized on immunoblots 
  using a T7 monoclonal antibody (Novagen). GST-Claspin CKBD shift assays 
were performed by adding bacterially expressed GST-Claspin CKBD (ﬁ  nal 
concentration: 50 ng/μl) to extract followed by visualization with anti-GST 
antibody (GE Healthcare; Kumagai and Dunphy, 2003). The Claspin–
Chk1 interaction assay was performed exactly as described previously 
(Jeong et al., 2003).
Expression vectors
Xmus101 BRCT 1–8 (FL) corresponds to full-length Xmus101 (nucleotides 
1–4542) subcloned into pCS2 + MT. Mini corresponds to Xmus101 nucle-
otides 1–2277 subcloned into pCS2 + MT. For transcription/translation 
in vitro, a TNT SP6 Quick Master Mix kit (Promega) was used in all cases. 
Chk1∆KD has been described (Michael et al., 2000). GST-Claspin CKBD 
was produced by subcloning X. laevis Claspin nucleotides 2609–2779 
into pGEX-4T-1. Xchk1-GH has been described previously (Kumagai and 
Dunphy, 2000). GST-CT333 was produced by subcloning Xmus101 
  nucleotides 3540–4542 into pGEX-4T-1.
Recombinant proteins
Chk1∆KD was expressed as a His-tagged fusion protein in Escherichia coli 
and puriﬁ  ed over nickel NTA agarose according to standard procedures. 
Recombinant Xchk1-GH was produced via infection of Sf9 insect cells. 
  Puriﬁ  cation of Xchk1-GH over a nickel NTA agarose column was performed 
as described previously (Kumagai and Dunphy, 2000). GST, GST-Claspin 
CKBD, and GST-CT333 were expressed in E. coli and puriﬁ  ed over gluta-
thione agarose according to standard procedures.
Antibodies
The anti-Xmus101 HU142 antibody and its afﬁ  nity puriﬁ  cation have been 
described (Van Hatten et al., 2002). Antibodies against the p70 subunit 
of pol α have been described (Stokes and Michael, 2003). Antibodies 
against Claspin were produced by W. Dunphy (California Institute of 
  Technology, Pasadena, CA). Antibodies against Chk1 and serine 344–
phosphorylated Chk1 were obtained from Santa Cruz Biotechnology, Inc., 
and Cell Signaling Technology, respectively. Antibodies against MCM5 
were obtained from Bethyl Laboratories.
Online supplemental material
Figure S1 shows that Chk1∆KD is a reliable surrogate for endogenous 
Chk1 in the AT70 checkpoint system. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200601076/DC1.
Figure 5.  HU142 allows mitosis in aphidicolin-treated cycling extracts. 
(A) Cycling extracts were prepared and supplemented with sperm chro-
matin (1,000/μl). Extracts were further supplemented, where indicated, with 
aphidicolin, HU142, or 5 mM of caffeine. Entry into mitosis was deter-
mined by nuclear envelope breakdown. (B) Egg extracts were prepared 
and supplemented with sperm chromatin and HU142, as indicated. DNA 
replication was then assessed as in Fig. 4 C.JCB • VOLUME 173 • NUMBER 2 • 2006  186
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